Related Experiment Video
Updated: Feb 25, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Integrating Models to Quantify Environment-Mediated Drug Resistance
Noemi Picco1,2, Erik Sahai3, Philip K Maini2
1Integrated Mathematical Oncology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. noemi.picco@maths.ox.ac.uk.
Mathematical modeling revealed how tumor-stroma interactions drive drug resistance in BRAF-mutated melanoma, distinguishing intrinsic and extrinsic resistance factors. This work bridges experimental and theoretical models for better treatment strategies.
Area of Science:
- Oncology
- Mathematical Biology
- Cancer Research
Background:
- Drug resistance is a primary cause of treatment failure in targeted cancer therapies.
- Tumor-stroma interactions influence treatment response through signaling pathways.
Purpose of the Study:
- To investigate tumor-stroma interactions in facilitating drug resistance.
- To differentiate intrinsic and extrinsic resistance components in BRAF-mutated melanoma using mathematical modeling.
Main Methods:
- Utilized mathematical modeling to simulate tumor-stroma dynamics with and without targeted therapy.
- Integrated experimental data to parameterize and validate the model.
- Analyzed variations in stromal promotion and tissue carrying capacity.
Main Results:
- Identified significant variability in stromal influence and intrinsic tissue capacity across experimental replicates.
- The model successfully separated intrinsic and extrinsic factors contributing to drug resistance.
- Demonstrated the role of tumor-stroma crosstalk in acquired resistance.
Conclusions:
- Tumor-stroma interactions play a critical role in the development of drug resistance in BRAF-mutated melanoma.
- Mathematical modeling provides a framework to understand complex biological systems and resistance mechanisms.
- Findings highlight the need to consider the tumor microenvironment in designing effective cancer therapies.
More Related Videos
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pharmacodynamic Models: Overview
Pharmacodynamic Models: Emax Drug–Concentration Effect Model
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...